EU-PRODUCT_SAFETY-ART_2
EU-PRODUCT_SAFETY-ART_2
General Product Safety Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of General Product Safety Directive (2001/95/EC), 15 January 2002, amended by Reg 596/2009/EC, 18 July 2009
This list contains a non-exhaustive inventory of substances that fall within the European Union's hazardous substance definitions, as provided on: (1) Table 3 of Annex VI to the CLP Regulation 1272/2008/EC; (2) Annex III of Directive 2000/54/EC (Biological Agents); Candidate List of SVHCs; and REACH Annexes XIV and XVII (Authorisation and Restriction lists). They can be considered hazardous for purposes of the General Product Safety Directive 2001/95/EC.
Last updated 26 avril 2024. Database contains 5503 unique substances/entries.
Filter the list
|
-
|
-
|
B Bacteria and similar species |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
TILCOM HTB
|
411-740-2
|
22411-22-9
|
yes |
||||
|
600-130-3
|
100784-20-1
|
yes |
Annex 17 Appendix 6 |
||||
|
HALOXYFOP ETHOXYETHYL EST
|
402-560-5
|
87237-48-7
|
yes |
||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
12035-71-1
|
yes |
Annex 17 Appendix 1 |
||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
218-165-4
|
2058-94-8
|
yes |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
200-962-3
|
76-44-8
|
yes |
|||||
|
213-831-0
|
1024-57-3
|
yes |
|||||
|
206-803-4
|
376-06-7
|
yes |
|||||
|
203-767-1
|
110-43-0
|
yes |
|||||
|
203-388-1
|
106-35-4
|
yes |
|||||
|
204-608-9
|
123-19-3
|
yes |
|||||
|
205-563-8
|
142-82-5
|
yes |
|||||
|
203-838-7
|
111-14-8
|
yes |
|||||
|
245-737-0
|
23560-59-0
|
yes |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
show/hide
|
247-148-4
|
25637-99-4
|
yes |
yes |
yes |
||
|
204-129-5
|
116-16-5
|
yes |
|||||
|
204-273-9
|
118-74-1
|
yes |
Annex 17 Appendix 2 |
||||
|
201-029-3
|
77-47-4
|
yes |
|||||
|
200-666-4
|
67-72-1
|
Annex 17 |
|||||
|
show/hide
Platinate(2-), hexachloro-, dihydrogen, (OC-6-11)-, reaction products with palladium
EC / List no:
-
| CAS no:
68516-04-1
Platinate(2-), hexachloro-, (OC-6-11)-, dihydrogen, reaction products with tributylphosphine hydrochloride and N-(3-(trimethoxysilyl)propyl)-1,2-ethanediamine
EC / List no:
-
| CAS no:
67924-25-8
Platinate(2-), hexachloro-, (OC-6-11)-, dihydrogen, reaction products with 2,4,6,8-tetraethenyl-2,4,6,8-tetramethylcyclotetrasiloxane
EC / List no:
271-555-6
| CAS no:
68585-32-0
Dihydrogen hexachloroplatinate, compound with 1,1,3,3-tetramethyl-1,3-divinyldisiloxane
EC / List no:
258-092-5
| CAS no:
52672-74-9
|
-
|
-
|
yes |
||||
|
241-010-7
|
16941-12-1
|
yes |
|||||
|
HEXACONAZOLE
|
413-050-7
|
79983-71-4
|
yes |
||||
|
424-830-1
|
220229-87-8
|
yes |
|||||
|
428-140-1
|
210706-50-6
|
yes |
|||||
|
C-1742
|
418-550-9
|
168689-49-4
|
yes |
||||
|
401-400-1
|
86479-06-3
|
yes |
|||||
|
204-127-4
|
116-15-4
|
yes |
|||||
|
256-356-4
|
48122-14-1
|
yes |
yes |
||||
|
260-566-1
|
57110-29-9
|
yes |
yes |
||||
|
243-072-0
|
19438-60-9
|
yes |
yes |
||||
|
AMINAZA TOLFAMATATE
|
418-350-1
|
-
|
yes |
||||
|
247-094-1
|
25550-51-0
|
yes |
yes |
||||
|
DIRECT RED 227, TETRAMETHYLAMMONIUM SALT
|
405-160-9
|
124537-30-0
|
yes |
||||
|
235-921-9
|
13048-33-4
|
yes |
|||||